We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors Likely to Influence Colgate (CL) in Q1 Earnings
Read MoreHide Full Article
Colgate-Palmolive Company (CL - Free Report) is slated to release first-quarter 2021 results on Apr 30, before the opening bell. The leading global consumer products company is expected to have witnessed revenue and earnings growth in the to-be-reported quarter.
The Zacks Consensus Estimate for Colgate’s first-quarter earnings is pegged at 80 cents per share, suggesting 6.7% growth from the year-ago quarter’s reported figure. The consensus estimate has moved north by a penny in the past 30 days. For first-quarter revenues, the consensus mark is pegged at $4.27 billion, suggesting 4.3% growth from the prior-year reported figure.
In the last reported quarter, the global consumer products company delivered earnings of 77 cents per share, in line with the Zacks Consensus Estimate. Moreover, the company recorded an earnings surprise of nearly 5%, on average, in the trailing four quarters.
Factors to Note
Colgate has been gaining from continued strong demand for personal and home care products as well as the finest innovation across product categories. Its categories like liquid hand soap, dish liquid, bar soap and cleaners across all geographies have been contributing to the top line amid the coronavirus pandemic. Also, strong volume growth and robust pricing have been key growth drivers.
The company has been witnessing gross margin expansion for the past few quarters, driven by robust pricing and productivity gains. Notably, its commitment toward pricing efforts through premiumization and revenue-growth management has been paying off. This is expected to have resulted in organic sales growth and gross margin expansion in the to-be-reported quarter.
Moreover, Colgate has been experiencing positive trends in the e-commerce platform, led by growth in the Hill’s business. The company has increased its focus on the online platform as more consumers are using online services for their essential needs, given the COVID-19 outbreak. We expect the robust online trend to have continued in the first quarter, which is expected to get reflected in the company’s top-line results.
Additionally, Colgate has been benefiting from innovation and in-store implementation, which have been the guiding principles of its growth strategy. It has been focused on expanding the availability of its products through enhanced distribution to newer markets and channels, which is likely to have helped improve its organic sales performance. It has been focused on the premiumization of its Oral Care portfolio through major innovations.
Apart from North America, innovation in naturals and whitening has been driving growth in the Latin America division, whereas premium innovation has been aiding the Colgate China business. Innovations along with accelerated investments in brands and higher pricing are likely to have aided the top line.
However, concerns related to higher selling, general and administrative expenses, advertising expenses, unfavorable currency fluctuations, and stiff competition cannot be ignored. Moreover, any escalation in raw and packaging-material expenses is expected to have impacted margins to an extent.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Colgate this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Colgate has a Zacks Rank #3 and an Earnings ESP of 0.00%.
Stocks With the Favorable Combination
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat.
Coty Inc. (COTY - Free Report) currently has an Earnings ESP of +350.00% and a Zacks Rank #3.
Tyson Foods, Inc. (TSN - Free Report) has an Earnings ESP of +16.03% and a Zacks Rank #3 at present.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Image: Bigstock
Factors Likely to Influence Colgate (CL) in Q1 Earnings
Colgate-Palmolive Company (CL - Free Report) is slated to release first-quarter 2021 results on Apr 30, before the opening bell. The leading global consumer products company is expected to have witnessed revenue and earnings growth in the to-be-reported quarter.
The Zacks Consensus Estimate for Colgate’s first-quarter earnings is pegged at 80 cents per share, suggesting 6.7% growth from the year-ago quarter’s reported figure. The consensus estimate has moved north by a penny in the past 30 days. For first-quarter revenues, the consensus mark is pegged at $4.27 billion, suggesting 4.3% growth from the prior-year reported figure.
In the last reported quarter, the global consumer products company delivered earnings of 77 cents per share, in line with the Zacks Consensus Estimate. Moreover, the company recorded an earnings surprise of nearly 5%, on average, in the trailing four quarters.
Factors to Note
Colgate has been gaining from continued strong demand for personal and home care products as well as the finest innovation across product categories. Its categories like liquid hand soap, dish liquid, bar soap and cleaners across all geographies have been contributing to the top line amid the coronavirus pandemic. Also, strong volume growth and robust pricing have been key growth drivers.
The company has been witnessing gross margin expansion for the past few quarters, driven by robust pricing and productivity gains. Notably, its commitment toward pricing efforts through premiumization and revenue-growth management has been paying off. This is expected to have resulted in organic sales growth and gross margin expansion in the to-be-reported quarter.
Moreover, Colgate has been experiencing positive trends in the e-commerce platform, led by growth in the Hill’s business. The company has increased its focus on the online platform as more consumers are using online services for their essential needs, given the COVID-19 outbreak. We expect the robust online trend to have continued in the first quarter, which is expected to get reflected in the company’s top-line results.
ColgatePalmolive Company Price and EPS Surprise
ColgatePalmolive Company price-eps-surprise | ColgatePalmolive Company Quote
Additionally, Colgate has been benefiting from innovation and in-store implementation, which have been the guiding principles of its growth strategy. It has been focused on expanding the availability of its products through enhanced distribution to newer markets and channels, which is likely to have helped improve its organic sales performance. It has been focused on the premiumization of its Oral Care portfolio through major innovations.
Apart from North America, innovation in naturals and whitening has been driving growth in the Latin America division, whereas premium innovation has been aiding the Colgate China business. Innovations along with accelerated investments in brands and higher pricing are likely to have aided the top line.
However, concerns related to higher selling, general and administrative expenses, advertising expenses, unfavorable currency fluctuations, and stiff competition cannot be ignored. Moreover, any escalation in raw and packaging-material expenses is expected to have impacted margins to an extent.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Colgate this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Colgate has a Zacks Rank #3 and an Earnings ESP of 0.00%.
Stocks With the Favorable Combination
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat.
Energizer Holdings, Inc. (ENR - Free Report) presently has an Earnings ESP of +9.67% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Coty Inc. (COTY - Free Report) currently has an Earnings ESP of +350.00% and a Zacks Rank #3.
Tyson Foods, Inc. (TSN - Free Report) has an Earnings ESP of +16.03% and a Zacks Rank #3 at present.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>